Dr. Carl Gordon
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Carl Gordon
Earlier roles on record: Board Member at Disc Medicine, Inc. (IRON) until December 29, 2022. Keros Therapeutics, Inc. reported in an 8-K filed February 26, 2026 that Dr. Carl Gordon resigned as director, effective March 9, 2026. Disc Medicine, Inc. reported in an 8-K filed December 29, 2022 that Dr. Carl Gordon resigned as director, effective December 29, 2022.
“On February 20, 2026, Dr. Carl Gordon notified the Board of his intention to resign from the Board, including from the Compensation Committee, effective March 9, 2026.”
“Carl Gordon, Ph.D., CFA, David Lubner, Tuyen Ong, M.D., MRCOphth., Jason Rhodes and Jim Tananbaum, M.D. resigned from the Company's board of directors and committees of the board of directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-02-05–2022-12-29
-
2016-01-01–2022-12-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.